By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Elizabeth Dragon, the former executive at Sequenom who admitted to lying about the firm's Trisomy 21 test, which led to an artificial inflation in the company's stock price, has died five months before she was to be sentenced for committing securities fraud.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.